GlassScriptPhysician profile
William S Douglas
NPI 1881049153
$513.63
in general payments reported to CMS, 2019-2025
9 companies · $112 in 2025
The $112 reported for 2025 was less than what a typical Sports Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $119).
See the full distribution for Sports Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $42.80 · 2022: $26.99 · 2023: $75.70 · 2024: $256 · 2025: $112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $444.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $443.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spr Therapeutics, INC | $230.66 | 2022-2025 | Sprint Pns System |
| Abbvie INC. | $78.93 | 2023-2024 | Botox |
| Merz Pharmaceuticals, LLC | $42.80 | 2021 | |
| Scilex Pharmaceuticals INC. | $41.81 | 2024-2025 | |
| Integra Lifesciences Corporation | $32.94 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Vertos Medical, INC. | $27.20 | 2023 | Mild Device Kit |
| Ipsen Biopharmaceuticals, INC | $23.31 | 2024 | Dysport |
| Endo USA, INC. | $19.73 | 2025 | Xiaflex |
| Avanos Medical | $16.25 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Douglas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.